BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 31254006)

  • 1. Relevance of VEGFA in rat livers subjected to partial hepatectomy under ischemia-reperfusion.
    Bujaldon E; Cornide-Petronio ME; Gulfo J; Rotondo F; Ávalos de León C; Negrete-Sánchez E; Gracia-Sancho J; Novials A; Jiménez-Castro MB; Peralta Uroz C
    J Mol Med (Berl); 2019 Sep; 97(9):1299-1314. PubMed ID: 31254006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resistin and visfatin in steatotic and non-steatotic livers in the setting of partial hepatectomy under ischemia-reperfusion.
    Elias-Miró M; Mendes-Braz M; Cereijo R; Villarroya F; Jiménez-Castro MB; Gracia-Sancho J; Guixé-Muntet S; Massip-Salcedo M; Domingo JC; Bermudo R; Rodés J; Peralta C
    J Hepatol; 2014 Jan; 60(1):87-95. PubMed ID: 23968888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retinol binding protein 4 and retinol in steatotic and nonsteatotic rat livers in the setting of partial hepatectomy under ischemia/reperfusion.
    Elias-Miró M; Massip-Salcedo M; Raila J; Schweigert F; Mendes-Braz M; Ramalho F; Jiménez-Castro MB; Casillas-Ramírez A; Bermudo R; Rimola A; Rodes J; Peralta C
    Liver Transpl; 2012 Oct; 18(10):1198-208. PubMed ID: 22685091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of glucose and lipids in steatotic and non-steatotic livers in conditions of partial hepatectomy under ischaemia-reperfusion.
    Mendes-Braz M; Elias-Miró M; Kleuser B; Fayyaz S; Jiménez-Castro MB; Massip-Salcedo M; Gracia-Sancho J; Ramalho FS; Rodes J; Peralta C
    Liver Int; 2014 Aug; 34(7):e271-89. PubMed ID: 24107124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are angiotensin II receptor antagonists useful strategies in steatotic and nonsteatotic livers in conditions of partial hepatectomy under ischemia-reperfusion?
    Ramalho FS; Alfany-Fernandez I; Casillas-Ramirez A; Massip-Salcedo M; Serafín A; Rimola A; Arroyo V; Rodés J; Roselló-Catafau J; Peralta C
    J Pharmacol Exp Ther; 2009 Apr; 329(1):130-40. PubMed ID: 19116369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endoplasmic reticulum stress inhibition protects steatotic and non-steatotic livers in partial hepatectomy under ischemia-reperfusion.
    Ben Mosbah I; Alfany-Fernández I; Martel C; Zaouali MA; Bintanel-Morcillo M; Rimola A; Rodés J; Brenner C; Roselló-Catafau J; Peralta C
    Cell Death Dis; 2010 Jul; 1(7):e52. PubMed ID: 21364657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of cortisol in steatotic and non-steatotic liver surgery.
    Cornide-Petronio ME; Bujaldon E; Mendes-Braz M; Avalos de León CG; Jiménez-Castro MB; Álvarez-Mercado AI; Gracia-Sancho J; Rodés J; Peralta C
    J Cell Mol Med; 2017 Oct; 21(10):2344-2358. PubMed ID: 28374452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adiponectin and resistin protect steatotic livers undergoing transplantation.
    Jiménez-Castro MB; Casillas-Ramírez A; Mendes-Braz M; Massip-Salcedo M; Gracia-Sancho J; Elias-Miró M; Rodés J; Peralta C
    J Hepatol; 2013 Dec; 59(6):1208-14. PubMed ID: 23867317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intermittent Ischemic Preconditioning Protects Against Hepatic Ischemia-Reperfusion Injury and Extensive Hepatectomy in Steatotic Rat Liver.
    Sikalias N; Karatzas T; Alexiou K; Mountzalia L; Demonakou M; Kostakis ID; Zacharioudaki A; Papalois A; Kouraklis G
    J Invest Surg; 2018 Oct; 31(5):366-377. PubMed ID: 28644700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of peroxisome proliferator-activated receptor-alpha inhibits the injurious effects of adiponectin in rat steatotic liver undergoing ischemia-reperfusion.
    Massip-Salcedo M; Zaouali MA; Padrissa-Altés S; Casillas-Ramirez A; Rodés J; Roselló-Catafau J; Peralta C
    Hepatology; 2008 Feb; 47(2):461-72. PubMed ID: 18098300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of angiotensin II action protects rat steatotic livers against ischemia-reperfusion injury.
    Casillas-Ramirez A; Amine-Zaouali M; Massip-Salcedo M; Padrissa-Altés S; Bintanel-Morcillo M; Ramalho F; Serafín A; Rimola A; Arroyo V; Rodés J; Roselló-Catafau J; Peralta C
    Crit Care Med; 2008 Apr; 36(4):1256-66. PubMed ID: 18379253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Addition of carvedilol to University Wisconsin solution improves rat steatotic and nonsteatotic liver preservation.
    Ben Mosbah I; Roselló-Catafau J; Alfany-Fernandez I; Rimola A; Parellada PP; Mitjavila MT; Lojek A; Ben Abdennebi H; Boillot O; Rodés J; Peralta C
    Liver Transpl; 2010 Feb; 16(2):163-71. PubMed ID: 20104484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Effect of Fibroblast Growth Factor 15 Signaling in Non-Steatotic and Steatotic Liver Transplantation from Cardiocirculatory Death.
    Avalos-de León CG; Jiménez-Castro MB; Cornide-Petronio ME; Gulfo J; Rotondo F; Gracia-Sancho J; Casillas-Ramírez A; Peralta C
    Cells; 2019 Dec; 8(12):. PubMed ID: 31847428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of N-acetylcysteine and anti-intercellular adhesion molecule-1 monoclonal antibody against ischemia-reperfusion injury of the rat steatotic liver produced by a choline-methionine-deficient diet.
    Nakano H; Nagasaki H; Barama A; Boudjema K; Jaeck D; Kumada K; Tatsuno M; Baek Y; Kitamura N; Suzuki T; Yamaguchi M
    Hepatology; 1997 Sep; 26(3):670-8. PubMed ID: 9303498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preservation of steatotic livers in IGL-1 solution.
    Ben Mosbah I; Roselló-Catafau J; Franco-Gou R; Abdennebi HB; Saidane D; Ramella-Virieux S; Boillot O; Peralta C
    Liver Transpl; 2006 Aug; 12(8):1215-23. PubMed ID: 16724331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of Neuregulin-1 in Steatotic and Non-Steatotic Liver Transplantation from Brain-Dead Donors.
    Micó-Carnero M; Casillas-Ramírez A; Sánchez-González A; Rojano-Alfonso C; Peralta C
    Biomedicines; 2022 Apr; 10(5):. PubMed ID: 35625715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rho inhibitor prevents ischemia-reperfusion injury in rat steatotic liver.
    Kuroda S; Tashiro H; Igarashi Y; Tanimoto Y; Nambu J; Oshita A; Kobayashi T; Amano H; Tanaka Y; Ohdan H
    J Hepatol; 2012 Jan; 56(1):146-52. PubMed ID: 21756846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved rat steatotic and nonsteatotic liver preservation by the addition of epidermal growth factor and insulin-like growth factor-I to University of Wisconsin solution.
    Zaouali MA; Padrissa-Altés S; Ben Mosbah I; Alfany-Fernandez I; Massip-Salcedo M; Casillas-Ramirez A; Bintanel-Morcillo M; Boillot O; Serafin A; Rimola A; Rodés J; Roselló-Catafau J; Peralta C
    Liver Transpl; 2010 Sep; 16(9):1098-111. PubMed ID: 20818748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ischemic preconditioning attenuates ischemia/reperfusion injury in rat steatotic liver: role of heme oxygenase-1-mediated autophagy.
    Liu A; Guo E; Yang J; Li R; Yang Y; Liu S; Hu J; Jiang X; Dirsch O; Dahmen U; Sun J; Ouyang M
    Oncotarget; 2016 Nov; 7(48):78372-78386. PubMed ID: 27852058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin-like growth factor and epidermal growth factor treatment: new approaches to protecting steatotic livers against ischemia-reperfusion injury.
    Casillas-Ramírez A; Zaouali A; Padrissa-Altés S; Ben Mosbah I; Pertosa A; Alfany-Fernández I; Bintanel-Morcillo M; Xaus C; Rimola A; Rodés J; Roselló-Catafau J; Peralta C
    Endocrinology; 2009 Jul; 150(7):3153-61. PubMed ID: 19282385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.